Apogee Therapeutics, Inc. Common Stock — 四半期決算報告書 (NASDAQ:APGE) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

Market Capitalization 5.0018 B
Employee 261
Founded 2022
CEO N/A
Website www.apogeetherapeutics.com
Headquarter Massachusetts, United States
FIGI BBG01H51WYQ5
Industry Technology

総売上高

当期純利益

1株当たり基本利益（基本EPS）

有利子負債合計

フリーキャッシュフロー

現金および現金同等物

5 B 時価総額

ニュース

Spyre Therapeutics Flies On Takeda-Rivaling Ulcerative Colitis Results

Why Delta, Starbucks and these other stocks were just added to a market-beating ‘fresh money’ list

Apogee Therapeutics: 'Strong Buy' As Zumilokibart Progresses To Next Q2 Milestone (APGE)

APGE Stock Up as Skin Disease Drug Shows Sustained 52-Week Efficacy

Apogee Therapeutics, Inc. (APGE) Discusses 52-Week Phase 2 APEX Data for Zumilokibart in Moderate to Severe Atopic Dermatitis Transcript

Apogee Therapeutics: Two Shots A Year, One Shot At Disruption (NASDAQ:APGE)

Apogee Therapeutics, Inc. (APGE) Discusses 52-Week Phase 2 APEX Data for Zumilokibart in Moderate to Severe Atopic Dermatitis - Slideshow (NASDAQ:APGE) 2026-03-23

How Apogee, Up Almost 20%, Plans To Take On Rival Regeneron's Eczema Drug

Apogee Therapeuticsの最高経営責任者Henderson氏が150万ドル相当の株式を売却

Apogee Therapeutics CEO Henderson sells $1.5 million in stock

RBC Capital、投与見通しを理由にApogee Therapeuticsの目標株価を引き下げ

RBC Capital lowers Apogee Therapeutics stock price target on dosing outlook